Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
XRTX XORTX Therapeutics
- 0.9000
- -0.0600-6.25%
Close Feb 14 16:00 ET
- 0.8999
- -0.0001-0.01%
Post 17:24 ET
2.90MMarket Cap7.50P/E (TTM)
0.9700High0.8783Low244.85KVolume0.9700Open0.9600Pre Close205.75KTurnover7.87%Turnover RatioLossP/E (Static)3.22MShares7.000052wk High1.36P/B2.80MFloat Cap0.850052wk Low--Dividend TTM3.11MShs Float55.0800Historical High--Div YieldTTM9.55%Amplitude0.8500Historical Low0.8400Avg Price1Lot Size
About XORTX Therapeutics Company
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Company Profile
SymbolXRTX
Company NameXORTX Therapeutics
Listing DateOct 13, 2021
Founded2011
CEODr. Allen Warren Davidoff, PhD
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address3710–33rd Street NW
CityCalgary
ProvinceAlberta
CountryCanada
Zip CodeT2L 2M1
Phone1-403-455-7717
Websitehttp://www.xortx.com
Company Executives
- Name
- Position
- Salary
- Dr. Allen Warren Davidoff, PhD
- President, Chief Executive Officer and Director
- 378.44K
- Dr. Stacy Evans
- Chief Business Officer
- 280.00K
- James Fairbairn
- Chief Financial Officer
- 76.20K
- Dr. Stephen Haworth
- Chief Medical Officer
- 215.27K
- Anthony J. Giovinazzo, B.A.,L.L.B.,M.B.A.
- Non Executive Chairman of the Board
- 133.97K
- Abigail L. Jenkins, B.A.,M.S.
- Director
- --
- Patrick Treanor, M.B.A.
- Director
- 12.90K
- Dr. Raymond Pratt
- Independent Director
- 9.76K
- Paul Joseph Van Damme, C.P.A.,M.B.A.
- Independent Director
- 10.87K
- William Farley
- Independent Director
- 10.43K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.